University Hospital Dusseldorf – Germany
About Prof. Dr. med. Hans Peter Hartung
Prof. Dr. med. Hans Peter Hartung is Professor and Chair of the Department of Neurology at Heinrich-Heine University Düsseldorf (since 2001) and Director of the Centre for Neurology and Neuropsychiatry (since 2012) — one of the world's leading neuroimmunologists with 900+ peer-reviewed publications, ECTRIMS President, and "Highly Cited Researcher 2017" (Web of Science).
- 40+ years of clinical and academic experience; 900+ peer-reviewed publications; 100 book chapters; 9 books edited
- MD — graduated 1980; Habilitation at Heinrich-Heine University Düsseldorf; undergraduate training at Universities of Düsseldorf, Glasgow, Oxford, Baltimore (Johns Hopkins), London (Queen Square)
- FRCP; FAAN (Fellow, American Academy of Neurology); FANA (Fellow, American Neurological Association); FEAN (Fellow, European Academy of Neurology)
- Director — Centre for Neurology and Neuropsychiatry, Düsseldorf (2012+); MS and GBS/CIDP Foundation International Centre of Excellence
- "Highly Cited Researcher 2017" — Web of Science; President ECTRIMS; Honorary Professor — University of Sydney
Qualifications & Credentials
Medical Degrees
- MD — Medical Graduation, 1980 (Undergraduate training at Universities of Düsseldorf, Glasgow, Oxford, Baltimore/Johns Hopkins, London/Queen Square)
- Habilitation — Neurology, Heinrich-Heine University Düsseldorf (as assistant professor in 1987)
Fellowships & Special Training
- Immunology Fellowship — Johannes Gutenberg University, Mainz (post-graduation)
- Professor & Head, MS Clinical Research Group, Vice Chair — Julius-Maximilians University Würzburg (1990)
- Chairman — University Department of Neurology, Karl-Franzens University Graz, Austria (1997)
- FRCP — Fellow, Royal College of Physicians
- FAAN — Fellow, American Academy of Neurology
- FANA — Fellow, American Neurological Association
- FEAN — Fellow, European Academy of Neurology
Certifications & Accreditations
- Honorary Professor — Brain & Mind Centre, University of Sydney, Australia
- Visiting Professor — Medical University Vienna, Austria
- Visiting Professor — Palacky University Olomouc, Czech Republic
- Director — Centre for Neurology and Neuropsychiatry, Heinrich-Heine University Düsseldorf (2012+)
- MS and GBS/CIDP Foundation International Centre of Excellence — in charge
Areas of Expertise
Major Conditions Treated
- Multiple Sclerosis (MS — all forms)
- Guillain-Barré Syndrome (GBS)
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Immune Neuropathies
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Parkinson's Disease & Movement Disorders
- Stroke
- Neuromuscular Disorders
Sub-specialties
- Multiple Sclerosis & Neuroimmunology: Global leader in MS research — author/co-author of landmark clinical trials (mitoxantrone, fingolimod, natalizumab) and 900+ publications — one of the most cited neurologists in the world; runs one of Europe's foremost MS clinical trial programmes at Düsseldorf.
- GBS, CIDP & Immune Neuropathies: Director of the GBS/CIDP Foundation International Centre of Excellence at Düsseldorf — internationally recognised authority on immune-mediated neuropathies.
Advanced Procedures & Treatments
- Disease-Modifying Therapy for MS (all approved agents)
- Immunoglobulin Therapy (IVIg) for GBS/CIDP
- Plasmapheresis
- Deep Brain Stimulation (DBS) — oversight
- Stroke Management (Unit oversight)
- Lumbar Puncture & CSF Biomarkers
- MRI-guided Neurological Assessment
Professional Experience
Current Affiliation
- Heinrich-Heine University Düsseldorf — Professor and Chair, Department of Neurology (Present, since 2001)
- Heinrich-Heine University Düsseldorf — Director, Centre for Neurology and Neuropsychiatry (Present, since 2012)
- Düsseldorf University Hospital — Medical Director, Department of Conservative Medicine (Present)
Past Affiliations
- Karl-Franzens University Graz, Austria — Chairman, Department of Neurology (1997–2001)
- Julius-Maximilians University Würzburg — Professor & Head, MS Research Group / Vice Chair, Neurology (1990–1997)
- Heinrich-Heine University Düsseldorf — Assistant Professor, Neurology (1987–1990)
Academic & Research Roles
- 900+ peer-reviewed publications; 100 book chapters; 9 books edited
- "Highly Cited Researcher 2017" — Web of Science
- President — ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis)
- Executive Board Member — European Charcot Foundation, GBS Foundation International, International Society of Neuroimmunology, MSIF (Medical Advisory Board), German MS Society
- Editorial Board — Annals of Neurology, Nature Reviews Neurology, JNNP, CNS Drugs, and numerous others
- Member — Numerous international MS and GBS clinical trials steering committees (phase 2 and 3)
Key Achievements
- 40+ years of academic and clinical neurology practice
- Chair, Dept. of Neurology, Heinrich-Heine University Düsseldorf (since 2001)
- Director, Centre for Neurology and Neuropsychiatry (since 2012)
- 900+ publications; 100 book chapters; 9 books edited
- "Highly Cited Researcher 2017" — Web of Science
- President — ECTRIMS
- Honorary Professor — University of Sydney Brain & Mind Centre
Awards & Recognitions
National & International Awards
- "Highly Cited Researcher 2017" — Web of Science
- FRCP — Fellow, Royal College of Physicians
- FAAN — Fellow, American Academy of Neurology
- FANA — Fellow, American Neurological Association
- FEAN — Fellow, European Academy of Neurology
- President — ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis)
- Honorary Professor — Brain & Mind Centre, University of Sydney, Australia
Professional Memberships
- American Academy of Neurology (FAAN)
- American Neurological Association (FANA)
- European Academy of Neurology (FEAN)
- European Charcot Foundation (Treasurer, Executive Board)
- GBS Foundation International (Executive Board)
- International Society of Neuroimmunology
- MSIF Medical Advisory Board
Research & Publications
Published Papers (Selected)
- Hartung HP, et al. "Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial." Lancet. 2002; 360:2018–2025.
- Cohen JA, Barkhof F, Comi G, Hartung HP, et al. "Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis." N Engl J Med. 2010; 362:402–415.
- Aktas O, Kieseier B, Hartung HP. "Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis." Trends Neurosci. 2010; 33:140–152.
- 900+ total peer-reviewed publications (full list available via ResearchGate and Düsseldorf University Hospital).
Ongoing Research & Clinical Interests
- Neuroimmunology — MS, GBS, CIDP, NMOSD
- Neural repair and remyelination strategies
- Biomarkers of MS disease activity and prognosis
- International phase 2/3 clinical trials in MS and immune neuropathies
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Neurology Consultation | €200 – €500 | $220 – $550 |
| MS Disease-Modifying Therapy (per year) | €20,000 – €60,000 | $22,000 – $66,000 |
| IVIg Therapy for GBS/CIDP (per course) | €5,000 – €15,000 | $5,500 – $16,500 |
| Plasmapheresis (per course) | €5,000 – €12,000 | $5,500 – $13,200 |
| In-patient Neurology (per day) | €500 – €1,500 | $550 – $1,650 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. med. Hans Peter Hartung use in Neurology treatment?
Prof. Dr. med. Hans Peter Hartung employs the full spectrum of disease-modifying therapies for MS, IVIg and plasmapheresis for GBS and CIDP, advanced MRI-guided neurological assessment, CSF biomarker analysis, and deep brain stimulation oversight. As "Highly Cited Researcher 2017" and a principal investigator on landmark MS trials published in The Lancet and NEJM, he provides globally benchmarked neuroimmunology care in Düsseldorf, Germany.
2. What conditions does Prof. Dr. med. Hans Peter Hartung specialize in treating?
Prof. Dr. med. Hans Peter Hartung specialises in multiple sclerosis (all forms), Guillain-Barré syndrome, CIDP, immune neuropathies, NMOSD, Parkinson's disease, and movement disorders. International patients seeking a world-leading MS and neuroimmunology specialist in Germany consult him at Heinrich-Heine University Düsseldorf.
3. How do I book an appointment with Prof. Dr. med. Hans Peter Hartung?
Appointments with Prof. Dr. med. Hans Peter Hartung can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. med. Hans Peter Hartung?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Hans Peter Hartung, including visa guidance, airport transfers, and accommodation coordination in Düsseldorf, Germany.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival in Germany.
6. Does Prof. Dr. med. Hans Peter Hartung offer second opinions for Neurology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their MS, GBS, CIDP, or other neurological diagnosis with one of the world's foremost neuroimmunologists at Heinrich-Heine University Düsseldorf.
